| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 21, 2006
From the Department of Congenital Heart Disease, Evelina Children’s Hospital, Guys’ and St Thomas’ NHS Trust (R.E.A.); the Cardiothoracic Unit, Great Ormond Street Hospital for Children NHS Trust (M.J.F., M.B.); and the Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health (D.A.R.); all in London, United Kingdom. * To whom correspondence should be addressed. E-mail: burchm{at}gosh.nhs.uk.
Background—We undertook the first prospective, national, multicenter study to describe the incidence and outcome of heart muscle disease–induced heart failure in children. Methods and Results—Data were collected on patients admitted to a hospital through 2003 with a first episode of heart failure in the absence of congenital heart disease. All 17 pediatric cardiac centers in the United Kingdom and Ireland participated. Follow-up data were obtained to a minimum of 1 year. The incidence was 0.87/100 000 population <16 years (n=104; 53 girls; 95% confidence interval 0.71 to 1.05 per 100 000). Median age at presentation was 1 year, with 82% in New York Heart Association class III to IV. Causes of heart failure included dilated cardiomyopathy (50 idiopathic, 8 familial), probable myocarditis (23), occult arrhythmia (7), anthracycline toxicity (5), metabolic disease (4), left ventricular noncompaction (3), and other (4). Overall 1-year survival was 82%, and event (death or transplantation)-free survival was 66%. Regression analysis showed older age and reduced systolic function on admission echocardiogram increased the event risk. Only 8% of event-free survivors (n=69) remained in New York Heart Association class III to IV, but 35 required readmission during the study period, and all but 8 remained on medication. Conclusions—This first national prospective study of new-onset heart failure in children has shown an incidence of 0.87/100 000. Multivariable analysis of survival data indicates a better outcome for younger children and for those with better systolic function at presentation, but overall, one third of children die or require transplantation within 1 year of presentation.
Accepted on October 19, 2007
New-Onset Heart Failure Due to Heart Muscle Disease in Childhood. A Prospective Study in the United Kingdom and Ireland
Rachel E. Andrews MRCPCH,
Related Article:
Circulation 2008 117: 1-3.
This article has been cited by other articles:
![]() |
T. P. Singh, L. A. Sleeper, S. Lipshultz, A. Cinar, C. Canter, S. A. Webber, D. Bernstein, E. Pahl, J. A. Alvarez, J. D. Wilkinson, et al. Association of Left Ventricular Dilation at Listing for Heart Transplant With Postlisting and Early Posttransplant Mortality in Children With Dilated Cardiomyopathy Circ Heart Fail, November 1, 2009; 2(6): 591 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Hsu and G. D. Pearson Heart Failure in Children: Part II: Diagnosis, Treatment, and Future Directions Circ Heart Fail, September 1, 2009; 2(5): 490 - 498. [Full Text] [PDF] |
||||
![]() |
D. T. Hsu and G. D. Pearson Heart Failure in Children: Part I: History, Etiology, and Pathophysiology Circ Heart Fail, January 1, 2009; 2(1): 63 - 70. [Full Text] [PDF] |
||||
![]() |
D. C. Sane Letter by Sane Regarding Article, "New-Onset Heart Failure Due to Heart Muscle Disease in Childhood: A Prospective Study in the United Kingdom and Ireland" Circulation, June 10, 2008; 117(23): e481 - e481. [Full Text] [PDF] |
||||
![]() |
S. A. Webber New-Onset Heart Failure in Children in the Absence of Structural Congenital Heart Disease Circulation, January 1, 2008; 117(1): 11 - 12. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |